Panagora Asset Management’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-205,382
Closed -$3.73M 1505
2022
Q2
$3.73M Buy
205,382
+49,397
+32% +$1.03M 0.02% 460
2022
Q1
$3.93M Sell
155,985
-449
-0.3% -$11.5K 0.02% 471
2021
Q4
$4.32M Buy
156,434
+9,836
+7% +$285K 0.02% 438
2021
Q3
$4.73M Buy
146,598
+319
+0.2% +$10.6K 0.03% 441
2021
Q2
$4.47M Buy
+146,279
New +$4.23M 0.02% 471
2017
Q3
Sell
-381
Closed -$10K 2437
2017
Q2
$10K Buy
+381
New +$8.09K ﹤0.01% 2412
2016
Q3
Sell
-1,850
Closed -$57K 2442
2016
Q2
$57K Sell
1,850
-34,822
-95% -$1.21M ﹤0.01% 2036
2016
Q1
$1.37M Buy
36,672
+28,279
+337% +$1.07M 0.01% 985
2015
Q4
$362K Buy
8,393
+6,543
+354% +$276K ﹤0.01% 1426
2015
Q3
$69K Hold
1,850
﹤0.01% 1910
2015
Q2
$63K Hold
1,850
﹤0.01% 2085
2015
Q1
$65K Hold
1,850
﹤0.01% 2038
2014
Q4
$63K Sell
1,850
-5,889
-76% -$209K ﹤0.01% 1977
2014
Q3
$298K Sell
7,739
-98,716
-93% -$3.68M ﹤0.01% 1486
2014
Q2
$4.14M Sell
106,455
-2,967
-3% -$110K 0.02% 573
2014
Q1
$3.74M Hold
109,422
0.02% 649
2013
Q4
$2.3M Buy
109,422
+10,466
+11% +$265K 0.01% 807
2013
Q3
$2.33M Buy
98,956
+4,265
+5% +$121K 0.01% 765
2013
Q2
$2.54M Buy
+94,691
New +$2.74M 0.01% 698

Other funds holding MYGN

Panagora Asset Management's MYGN Position: Q3 2022 in Review

Panagora Asset Management sold out of Myriad Genetics (MYGN) in Q3 2022, closing a stake of 205,382 shares — an estimated $3.73M sold.

Panagora Asset Management first reported a position in MYGN in Q2 2013 and held it in 19 quarters. The position peaked at $4.73M in Q3 2021. 191 funds tracked by Wall St. Rank hold MYGN as of Q3 2022.

  • Panagora Asset Management reported no remaining Myriad Genetics position as of Q3 2022 after selling out during the quarter.
  • Panagora Asset Management sold 205,382 Myriad Genetics shares in Q3 2022, an estimated $3.73M.
  • Panagora Asset Management first reported a position in Myriad Genetics in Q2 2013 and held it in 19 quarters.
  • Panagora Asset Management's Myriad Genetics position peaked at $4.73M in Q3 2021.
  • 191 funds tracked by Wall St. Rank held Myriad Genetics as of Q3 2022.

Based on Panagora Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.